RTHP-21. TREATMENTS FOR RECURRENT MALIGNANT GLIOMAS AND THEIR PROGNOSIS

For improvement of glioma therapy, advances in treatment after recurrence are essential, but no standard second line therapy has been estimated. Lately, bevacizumab (Bev) and BCNU wafer became available in Japan, we have more therapeutic choices. Since we took part in Kansai molecular diagnosis netw...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Mori, Kanji, Kumagai, Tetsuya, Kobayashi, Maki, Iwata, Takamitsu, Nakagawa, Kanji, Kudo, Akira, Toyota, Shingo, Kanemura, Yonehiro, Taki, Takuyu
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Radiation Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847888/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados